← All treatments

Surgical · day case

Minimally invasive bleb surgery & trabeculectomy

A new drainage route is created so fluid collects under the thin skin of the eye in a small blister, called a bleb.

How it works

A controlled opening is made so fluid can pass out of the eye and gather beneath the conjunctiva in a low blister. Trabeculectomy is the long-established version; newer minimally invasive bleb procedures achieve the same goal through a smaller opening using novel devices like Preserflo.

Preserflo MicroShunt (MIBS)

Preserflo is a small, soft tube that creates a new drainage route from inside the eye to beneath the conjunctiva, the thin membrane covering the white of the eye. Fluid collects in a small filtering bleb, usually hidden under the upper eyelid, and is then absorbed by the surrounding tissues. The tube remains in place. This is minimally invasive bleb surgery (MIBS): unlike drainage-angle MIGS, it directs fluid outside the eye's natural drainage system. A medicine such as mitomycin C is usually applied during surgery to reduce scarring and help keep the drainage route open.

Trabeculectomy

Trabeculectomy creates a new drainage opening using the eye's own tissue, rather than leaving a drainage tube in place. A small flap is made in the sclera, the white wall of the eye, and a tiny opening underneath allows fluid to pass into a filtering bleb beneath the conjunctiva. Stitches in the flap regulate the flow and may be adjusted or released during follow-up. A medicine such as mitomycin C is often used to reduce scarring. It is a well-established operation that can achieve low eye pressures and may be particularly suitable for advanced glaucoma or when a very low target pressure is needed.

Choosing between Preserflo and trabeculectomy

The choice is tailored to the severity of glaucoma, the target eye pressure, previous operations, the condition of the conjunctiva, the risk of scarring and the patient's circumstances. Neither procedure is the best option for every eye. Both aim to lower pressure and protect remaining vision; they cannot restore sight already lost to glaucoma. Potential risks include pressure that is too low, scarring that reduces drainage, infection and changes in vision. The expected benefits, risks and aftercare are discussed before choosing the most appropriate approach.

What to expect

Both give powerful pressure lowering and need close aftercare — frequent visits in the early weeks, drops, and sometimes small adjustments in clinic to fine-tune the drainage.

Other treatments